{"id":1459,"date":"2022-02-16T12:19:50","date_gmt":"2022-02-16T12:19:50","guid":{"rendered":"https:\/\/www.bioevents.net\/testweb\/?page_id=1459"},"modified":"2022-02-16T12:21:58","modified_gmt":"2022-02-16T12:21:58","slug":"message-for-italian-pharma-companies","status":"publish","type":"page","link":"https:\/\/www.bioevents.net\/testweb\/message-for-italian-pharma-companies\/","title":{"rendered":"Message for Italian Pharma Companies"},"content":{"rendered":"
In Italy each pharmaceutical company which sponsors a meeting or a congress on topics in anyway related to the use of their own pharmaceutical products, must submit to the competent Unit of the Italian Medicines Agency (AIFA) an application to obtain a specific authorization. This is in respect of an Italian Government Decree (Decreto Legislativo 219\/06 art. 124).<\/p>\n
The request of authorisation must be submitted within 60 day before the starting date of the event.<\/p>\n
In compliance with the given instructions please contact for the AIFA application documents:<\/p>\n
<\/p>\n
TWT SRL In Italy each pharmaceutical company which sponsors a meeting or a congress on topics in anyway related to the use of their own pharmaceutical products, must submit to the competent Unit of the Italian Medicines Agency (AIFA) an application to obtain a specific authorization. This is in respect of an Italian Government Decree (Decreto Legislativo […]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-1459","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\n
\n<\/strong>Gianni Frontani \u00a0& Anna Lupidi
\n<\/strong>Via Arrigo Davila n.130
\n00179 Roma, Italy
\nPhone +39 06 442 493 21
\nFax +39 06 99331533
\nE-Mail: g.frontani@twt-team.it<\/a><\/strong>\u00a0 \u00a0– alupidi@twt-team.it<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"